Twitter

Archive for May 9th, 2012


Survival Charges Pertaining To Esophageal Most Cancers

The tactical charge with regard to esophageal most cancers continues decreasing with each coming year which is typically agen xamthone plus bontang really low. The treatment with regard to esophageal cancers offers increased within the modern times and hence your tactical price has slightly increased. Initially your dangerous cell expansion begins in the wind pipe [...]

Read More...

Cervical Cancer: Stage 3B – Health Restored Part 1

Ai Hoa is a 78 year old lady. In May 2008 she had chocolate-coloured vaginal discharge. She consulted 2 gynaecologists and both told her, “… nothing was wrong …” Her daughter brought her to Singpaore of further consultation. A PAP smear done on 16 March 2009 indicated high grade squamous intraepithelial lesion (HSIL) / CIN 3. A biopsy indicated microinvasive squamous cell carcinoma. A PET-CT scan on 23 March 2009 indicated a hypermetabolic FDG cervical mass with diffusely increased uterine avidity which was inseparable from the uterus and the upper part of the vagina.There was metastasis, but no evidence of liver metastases. Blood test showed normal ESR, renal and liver function. Her CEA was 6.9 and CA 125 was 124. An endoscopy showed gastritis. She was tested positive for Helicobacter pylori. A colonoscopy showed numerous small polyps in her rectum. She was given Baraclude for the hepatitis B (being a carrier). On 25 March 2009, she underwent concurrent chemo-radiation treatment. Her health worsened. Listen to the conversation.

Read More...

Metformin in Pregnancy in Women With Polycystic Ovary Syndrome

Condition :   Polycystic Ovary Syndrome Intervention :   Drug: Metformin Sponsors :   Catholic University of the Sacred Heart;   Catholic University of the Sacred Heart Completed – verified May 2012

Read More...

Combination SBIRT for Emergency Department Patients Who Drink and Smoke

Conditions :   Smoking;   Drinking Intervention :   Behavioral: Combined BNI Sponsors :   Yale University;   Yale University Not yet recruiting – verified May 2012

Read More...

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Condition :   Neoplasms, Hematologic Interventions :   Drug: 200 mg LY2784544;   Drug: 400 mg LY2784544;   Drug: 600 mg LY2784544 Sponsors :   Eli Lilly and Company;   Eli Lilly and Company Not yet recruiting – verified May 2012

Read More...

Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer

Conditions :   Lung Cancer;   Non Small Cell Lung Cancer (NSCLC);   Breast Cancer;   ER+ Breast Cancer Interventions :   Drug: entinostat;   Drug: entinostat;   Drug: Erlotinib;   Drug: Erlotinib;   Drug: Exemestane;   Drug: Exemestane Sponsors :   Syndax Pharmaceuticals;   Syndax Pharmaceuticals Recruiting – verified May 2012

Read More...

Fractionated Radiosurgery for Painful Spinal Metastases

Conditions :   Neoplasm Metastasis;   Neoplastic Processes;   Neoplasm Recurrence, Local;   Neoplasm, Residual;   Pain Intervention :   Radiation: Radiosurgery Sponsors :   Wuerzburg University Hospital;   Wuerzburg University Hospital;   Royal Marsden NHS Foundation Trust Active, not recruiting – verified May 2012

Read More...

Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced Neuroendocrine Tumors

Condition :   Neuroendocrine Tumors Intervention :   Drug: RAD001 Sponsors :   Novartis;   Novartis Pharmaceuticals Not yet recruiting – verified May 2012

Read More...

Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia

Conditions :   Leukemia;   Lymphoma Interventions :   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: hydrocortisone sodium succinate;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: prednisone;   Drug: vincristine sulfate Sponsors :   National Cancer Institute (NCI);   Children’s Oncology Group;   National Cancer Institute (NCI) Not yet recruiting – verified May 2012

Read More...

Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients With Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy

Condition :   Metastatic Castration-resistant Prostate Cancer Interventions :   Drug: Cabazitaxel;   Drug: Mitoxantrone;   Drug: Prednisone;   Drug: Pegfilgrastim Sponsors :   University of California, San Francisco;   Andrea Harzstark;   Sanofi-Aventis Not yet recruiting – verified May 2012

Read More...